GSA Capital Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,291
Closed -$481K 1722
2024
Q3
$481K Buy
+7,291
New +$481K 0.04% 929
2023
Q4
Sell
-16,887
Closed -$1.17M 1620
2023
Q3
$1.17M Buy
+16,887
New +$1.17M 0.1% 316
2023
Q1
Sell
-6,279
Closed -$468K 1589
2022
Q4
$468K Sell
6,279
-5,097
-45% -$380K 0.06% 646
2022
Q3
$940K Sell
11,376
-115
-1% -$9.5K 0.12% 187
2022
Q2
$1.09M Buy
+11,491
New +$1.09M 0.16% 112
2021
Q4
Sell
-5,362
Closed -$607K 1512
2021
Q3
$607K Sell
5,362
-1,531
-22% -$173K 0.06% 581
2021
Q2
$714K Buy
+6,893
New +$714K 0.08% 402
2020
Q2
Sell
-8,454
Closed -$532K 748
2020
Q1
$532K Sell
8,454
-1,317
-13% -$82.9K 0.13% 141
2019
Q4
$760K Buy
+9,771
New +$760K 0.09% 371
2019
Q3
Sell
-9,156
Closed -$564K 1481
2019
Q2
$564K Buy
+9,156
New +$564K 0.06% 589
2018
Q1
Sell
-44,673
Closed -$1.68M 1658
2017
Q4
$1.68M Sell
44,673
-23,022
-34% -$865K 0.1% 307
2017
Q3
$2.47M Buy
67,695
+57,954
+595% +$2.11M 0.17% 88
2017
Q2
$384K Sell
9,741
-49,545
-84% -$1.95M 0.03% 1131
2017
Q1
$1.86M Buy
59,286
+49,224
+489% +$1.54M 0.1% 289
2016
Q4
$314K Buy
10,062
+3,048
+43% +$95.1K 0.02% 1301
2016
Q3
$282K Sell
7,014
-233,643
-97% -$9.39M 0.02% 1412
2016
Q2
$8M Buy
240,657
+213,330
+781% +$7.09M 0.44% 3
2016
Q1
$804K Sell
27,327
-29,721
-52% -$874K 0.05% 683
2015
Q4
$1.5M Buy
57,048
+35,598
+166% +$937K 0.07% 418
2015
Q3
$508K Sell
21,450
-33,546
-61% -$794K 0.03% 1115
2015
Q2
$1.31M Sell
54,996
-106,626
-66% -$2.53M 0.05% 686
2015
Q1
$3.84M Buy
161,622
+51,714
+47% +$1.23M 0.15% 94
2014
Q4
$2.33M Buy
+109,908
New +$2.33M 0.16% 109
2013
Q4
Sell
-52,638
Closed -$611K 1664
2013
Q3
$611K Buy
+52,638
New +$611K 0.05% 644